ALLO
Allogene TherapeuticsANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
ALLO vs peer average
78/100
ALLO vs. peer average (A vs. C)
Grade spread
A 3 · B 1 · C 4 · D 2 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
CADL is the first available peer comparator.
Loose same-size clinical biotech comparator from the packet; useful mainly for financing sensitivity and event-driven readout volatility rather than as a close operating peer.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ALLO
Allogene Therapeutics
CADL
Candel Therapeutics
Grade
A
C
Momentum
96
87
Value
41
41
Sentiment
56
34
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Mixed
Grade position vs CADL
ALLO / CADL
Grade Position
Above peers
ALLO vs. peer average (A vs. C)
78/100
Momentum
96
ALLOValue
41
ALLOSentiment
56
ALLORotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ALLO
CADL is the first peer returned for this comparison set.